|
Q4 2021
Filed on Feb 09, 2022
|
2,858
|
$82.14 - $115.55
$235K - $330K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
5,432
|
N/A
|
|
Pieris Pharmaceuticals Inc
|
Q4 2021
Filed on Feb 09, 2022
|
500,113
|
N/A
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
30,500
|
$24.49 - $29.2
$747K - $891K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
14,035
|
N/A
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
4,610
|
$74.55 - $86.94
$344K - $401K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
64,399
|
N/A
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
1,717
|
$63.0 - $160.29
$108K - $275K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
4,797
|
$48.59 - $58.2
$233K - $279K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
150,940
|
N/A
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
9,137
|
$33.96 - $46.24
$310K - $422K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
6,539
|
$33.38 - $59.25
$218K - $387K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
12,433
|
$15.1 - $15.92
$188K - $198K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
5,576
|
$110.75 - $140.13
$618K - $781K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
31,030
|
$4.2 - $5.64
$130K - $175K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
10,620
|
$85.15 - $104.16
$904K - $1.11M
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
75,020
|
N/A
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
173,323
|
$6.08 - $11.2
$1.05M - $1.94M
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
15,112
|
$21.47 - $32.08
$324K - $485K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
14,500
|
$11.66 - $12.38
$169K - $180K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
55,564
|
$31.86 - $33.07
$1.77M - $1.84M
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
5,928
|
$177.8 - $281.64
$1.05M - $1.67M
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
3,820
|
$136.3 - $180.96
$521K - $691K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
5,853
|
$39.32 - $61.61
$230K - $361K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
23,968
|
N/A
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
187,945
|
$7.24 - $9.83
$1.36M - $1.85M
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
21,122
|
$59.46 - $72.87
$1.26M - $1.54M
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
4,144
|
$75.52 - $89.52
$313K - $371K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
37,000
|
$9.8 - $10.13
$363K - $375K
|
|
Rivernorth Opportunities Fd Rt
|
Q4 2021
Filed on Feb 09, 2022
|
62,835
|
N/A
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
29,801
|
$13.01 - $14.73
$388K - $439K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
42,000
|
$5.96 - $10.01
$250K - $420K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
17,179
|
N/A
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
99,499
|
$37.72 - $47.02
$3.75M - $4.68M
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
37,000
|
$19.68 - $20.28
$728K - $750K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
41,552
|
$13.72 - $19.4
$570K - $806K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
31,177
|
$11.9 - $21.76
$371K - $678K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
5,496
|
$31.73 - $60.02
$174K - $330K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
6,420
|
$42.43 - $50.66
$272K - $325K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
6,313
|
$74.26 - $88.12
$469K - $556K
|
|
Nextgen Acquisition Corp Ii Class A
|
Q4 2021
Filed on Feb 09, 2022
|
60,330
|
N/A
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
15,741
|
$5.67 - $10.77
$89.3K - $170K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
23,792
|
$5.04 - $7.02
$120K - $167K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
7,561
|
$26.4 - $29.99
$200K - $227K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
35,054
|
$12.02 - $13.8
$421K - $484K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
38,369
|
N/A
|
|
Empowerment Inclusion Capita
|
Q4 2021
Filed on Feb 09, 2022
|
46,000
|
N/A
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
15,768
|
$50.91 - $58.37
$803K - $920K
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
81,090
|
$24.05 - $36.55
$1.95M - $2.96M
|
|
|
Q4 2021
Filed on Feb 09, 2022
|
48,049
|
$36.31 - $45.23
$1.74M - $2.17M
|
|